Skip to main content
Clinical Trials/NCT00695084
NCT00695084
Completed
Phase 1

Constraint-Induced Movement Therapy Trial for Progressive Multiple Sclerosis

National Multiple Sclerosis Society1 site in 1 country7 target enrollmentMarch 2007

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
National Multiple Sclerosis Society
Enrollment
7
Locations
1
Primary Endpoint
Improvement on the Motor Activity Log
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.

Detailed Description

Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to determine whether multiple sclerosis may benefit similarly from Constraint-Induced Movement Therapy.

Registry
clinicaltrials.gov
Start Date
March 2007
End Date
April 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Chronic upper extremity motor deficit due to multiple sclerosis

Exclusion Criteria

  • Relapse within 3 months of planned enrollment.

Outcomes

Primary Outcomes

Improvement on the Motor Activity Log

Time Frame: One year

Secondary Outcomes

  • Improvement on the Wolf Motor Function Test(Pre to post-treatment)

Study Sites (1)

Loading locations...

Similar Trials